To determine the suitability of existing performance measures for migraine treatment and assess the feasibility of recommending a core performance measure, while also identifying gaps and evaluating guideline-based recommendations.
Approach:
Key Findings:
No suitable core performance measure for migraine care was identified.
Only one existing measure related to imaging overuse was found, but it was not supported due to lack of testing and outdated guidelines.
Guideline-recommended treatment measures were deemed infeasible due to poor data capture in electronic health records, particularly for over-the-counter medications.
Interpretation:
Current limitations in migraine measurement reflect challenges in data capture and documentation rather than deficiencies in care quality.
Limitations:
Inadequate data capture for over-the-counter medications.
Lack of testing for existing performance measures.
Variability in documentation practices affecting reliability.
Conclusion:
The ACP does not recommend a core performance measure for migraine treatment, emphasizing the need for improved measurement strategies.
